Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Bonnet

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|June 13, 2025
Vat-Mediated Mucus Penetration Enables Genotoxic Activity of <i>pks+ Escherichia coli</i>Héloïse Chat, Léa Girondier, Guillaume Dalmasso, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2007
Modulation of gene expression as a new skin anti-aging strategySylvie Talbourdet, Neil S Sadick, Kristell Lazou, et al.
Frontiers in Microbiology|February 20, 2025
Biochemical characterization of the <i>Escherichia coli</i> surfaceome: a focus on type I fimbriae and flagellaDevon W Kavanaugh, Adeline Sivignon, Yannick Rossez, et al.
Clinical Science (London, England : 1979)|January 18, 2017
Interactions between microsatellite instability and human gut colonization by <i>Escherichia coli</i> in colorectal cancerJohan Gagnière, Virginie Bonnin, Anne-Sophie Jarrousse, et al.
BMJ Open|December 2, 2022
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)Christophe Taoum, Guillaume Carrier, Marta Jarlier, et al.
BMJ Open|January 10, 2020
Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)Julie Veziant, Karine Poirot, Caroline Chevarin, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
World Journal of Gastroenterology|June 11, 2014
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferationJennifer Raisch, Emmanuel Buc, Mathilde Bonnet, et al.
Investigational New Drugs|June 23, 2010
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitterMaryline Gardette, Janine Papon, Mathilde Bonnet, et al.
JAMA Dermatology|May 28, 2020
Secukinumab Therapy for Netherton SyndromeIsabelle Luchsinger, Nicole Knöpfel, Martin Theiler, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 13, 2025
Vat-Mediated Mucus Penetration Enables Genotoxic Activity of <i>pks+ Escherichia coli</i>Héloïse Chat, Léa Girondier, Guillaume Dalmasso, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2007
Modulation of gene expression as a new skin anti-aging strategySylvie Talbourdet, Neil S Sadick, Kristell Lazou, et al.
Frontiers in Microbiology|February 20, 2025
Biochemical characterization of the <i>Escherichia coli</i> surfaceome: a focus on type I fimbriae and flagellaDevon W Kavanaugh, Adeline Sivignon, Yannick Rossez, et al.
Clinical Science (London, England : 1979)|January 18, 2017
Interactions between microsatellite instability and human gut colonization by <i>Escherichia coli</i> in colorectal cancerJohan Gagnière, Virginie Bonnin, Anne-Sophie Jarrousse, et al.
BMJ Open|December 2, 2022
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)Christophe Taoum, Guillaume Carrier, Marta Jarlier, et al.
BMJ Open|January 10, 2020
Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)Julie Veziant, Karine Poirot, Caroline Chevarin, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
World Journal of Gastroenterology|June 11, 2014
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferationJennifer Raisch, Emmanuel Buc, Mathilde Bonnet, et al.
Investigational New Drugs|June 23, 2010
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitterMaryline Gardette, Janine Papon, Mathilde Bonnet, et al.
JAMA Dermatology|May 28, 2020
Secukinumab Therapy for Netherton SyndromeIsabelle Luchsinger, Nicole Knöpfel, Martin Theiler, et al.
Pageof 6